chartexchange

DNTH
Dianthus Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:54 PM EST
83.92USD-3.518%(-3.06)861,562
After-hoursNov 18, 2026 4:54:30 PM EST
84.07USD+0.179%(+0.15)
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Massachusetts, USA
Previous Close
$86.98
Beta
1.01
52-Week High
$117.88 2026-08-19
52-Week Low
$35.84 2026-01-06
SMA 50
$87.17
SMA 200
$87.43
Avg. Vol 10D
729,230
Avg. Vol 30D
912,398
Avg. Vol 90D
832,873
Relative Vol
0.94
46.82M
0.3600%
1,438
DNTH Profile

magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.

DNTH Performance
PeriodPriceDateChangeBeta
1W92.482026-11-12-9.19%0.234
1M74.542026-10-19+12.66%1.254
3M113.702026-08-19-26.14%1.224
6M85.672026-05-19-1.97%0.963
1Y40.792025-11-19+105.88%1.007
2Y22.272024-11-19+277.10%—
5Y12.512023-09-13+571.30%1.089
DNTH Stock Summary

Dianthus Therapeutics, Inc. Common Stock (NASDAQ:DNTH) stock price today is $83.98, and today's volume is 861,562. DNTH is down 3.449% today. The 30 day average volume is 912,398. DNTH market cap is $4.73B with 56.31M shares outstanding.